In healthcare, biotechnology has led to groundbreaking treatments like gene therapy and personalized medicine. These treatments can be life-saving, but they often come with exorbitant price tags. As a result, access is typically limited to patients in wealthy countries or those with robust healthcare coverage, leaving a vast portion of the global population without access to these innovations. This disparity is not only unethical but can also lead to global health crises where treatable diseases persist in poorer regions.
